Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chris Labaki

11PUBLICATIONS

83CO-AUTHORS

Predictive and prognostic markersSensory processes, perception and performanceMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Feb 20, 2026

Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and <i>BAP1</i> loss.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Nov 19, 2025

Prospective Validation of the First US FDA-Approved Computer-Aided Quality Assessment Tool for Colonoscopy: An Initial Clinical Experience.

Todd A Brenner, Chris Labaki, Joseph D Feuerstein

|Jan 09, 2025

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Tejas Jammihal, Renee Maria Saliby, Chris Labaki

|Nov 28, 2024

Single-cell epigenetic profiling reveals an interferon response-high program associated with <i>BAP1</i> deficiency in kidney cancer.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Nov 23, 2022

Perioperative immunotherapy for renal cell carcinoma: looking beyond the data.

Chris Labaki, Toni K Choueiri

|Mar 09, 2022

Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

Pageof 2

Frequent Collaborators

4 joint publications

Ziad Bakouny

4 joint publications

Toni K Choueiri

3 joint publications

Eliezer Van Allen

3 joint publications

Sabina Signoretti

2 joint publications

Eddy Saad

2 joint publications

Michael S Cuoco

2 joint publications

Jack Horst

2 joint publications

Breanna M Titchen

2 joint publications

Erica Pimenta

2 joint publications

Sabrina Y Camp

Frequent Collaborators

4 joint publications

Ziad Bakouny

4 joint publications

Toni K Choueiri

3 joint publications

Eliezer Van Allen

3 joint publications

Sabina Signoretti

Top Related Videos

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on : Apr 05, 2018

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on : Aug 01, 2019

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos

Top Related Videos

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on : Apr 05, 2018

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on : Aug 01, 2019

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos